Insider Transactions in Q2 2024 at Alpine Immune Sciences, Inc. (ALPN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2024
|
Christopher Peetz Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,900
-100.0%
|
-
|
|
May 20
2024
|
Robert E Conway Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
50,000
-100.0%
|
-
|
|
May 20
2024
|
Mitchell Gold Executive Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
109,245
-56.06%
|
-
|
|
May 20
2024
|
Stanford L Peng Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
344,163
-93.03%
|
-
|
|
May 20
2024
|
James Paul Rickey Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
57,961
-73.09%
|
-
|
|
May 20
2024
|
Remy Durand Chief Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
133,392
-88.31%
|
-
|
|
May 20
2024
|
Ulrich Martin Fuhs Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,120
-87.88%
|
-
|
|
May 18
2024
|
Peter A. Thompson Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,680,496
-100.0%
|
-
|
|
May 18
2024
|
James N Topper Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,829,347
-100.0%
|
-
|
|
May 18
2024
|
Mitchell Gold Executive Chairman and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,627,157
-100.0%
|
-
|
|
May 18
2024
|
Xiangmin Cui Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
8,317,924
-100.0%
|
-
|
|
May 18
2024
|
Orbimed Advisors LLC Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,680,496
-100.0%
|
-
|
|
May 08
2024
|
Remy Durand Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
95,288
+17.15%
|
$571,728
$6.36 P/Share
|
|
May 08
2024
|
Stanford L Peng Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
271,792
+12.88%
|
$1,358,960
$5.98 P/Share
|
|
May 08
2024
|
Ulrich Martin Fuhs Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,820
+43.11%
|
$273,840
$12.07 P/Share
|
|
May 08
2024
|
Mitchell Gold Executive Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,245
+10.81%
|
$92,715
$7.55 P/Share
|
|
May 07
2024
|
James Paul Rickey Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,761
+7.15%
|
$187,327
$7.8 P/Share
|
|
Apr 25
2024
|
James N Topper Director |
SELL
Open market or private sale
|
Indirect |
19
-0.0%
|
$1,216
$64.57 P/Share
|
|
Apr 25
2024
|
James N Topper Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,200,000
+29.78%
|
-
|